Nano-Topography Enhanced Topological-Cell-Analysis in Radiation-Therapy

Journal Article (2025)
Author(s)

Francesca Pagliari (German Cancer Research Center)

Maria-Francesca Spadea (Karlsruhe Institut für Technologie)

Pierre Montay-Gruel (Iridium Netwerk, Universiteit Antwerpen)

Anggraeini Puspitasari-Kokko (HollandPTC)

Joao Seco (German Cancer Research Center, Universität Heidelberg)

Luca Tirinato (University Magna Graecia)

A. Accardo (TU Delft - Mechanical Engineering)

Francesco De Angelis (Istituto Italiano di Tecnologia)

Francesco Gentile (University Magna Graecia)

Research Group
Micro and Nano Engineering
DOI related publication
https://doi.org/10.1002/adhm.202405187 Final published version
More Info
expand_more
Publication Year
2025
Language
English
Research Group
Micro and Nano Engineering
Journal title
Advanced Healthcare Materials
Issue number
12
Volume number
14
Article number
2405187
Downloads counter
194
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Radiotherapy (RT) is a cancer treatment technique that involves exposing cells to ionizing radiation, including X-rays, electrons, or protons. RT offers promise to treat cancer, however, some inherent limitations can hamper its performance. Radio-resistance, whether innate or acquired, refers to the ability of tumor cells to withstand treatment, making it a key factor in RT failure. This perspective hypothesizes that nanoscale surface topography can impact on the topology of cancer cells network under radiation, and that this understanding can possibly advance the assessment of cell radio-resistance in RT applications. An experimental plan is proposed to test this hypothesis, using cancer cells exposed to various RT forms. By examining the influence of 2D surface and 3D scaffold nanoscale architecture on cancer cells, this approach diverges from traditional methodologies, such as clonogenic assays, offering a novel viewpoint that integrates fields such as tissue engineering, artificial intelligence, and nanotechnology. The hypotheses at the base of this perspective not only may advance cancer treatment but also offers insights into the broader field of structural biology. Nanotechnology and label-free Raman phenotyping of biological samples are lenses through which scientists can possibly better elucidate the structure-function relationship in biological systems.